Khalid Shah, MS, PhD
Director, Center for Stem Cell Therapeutics and Imaging
Vice Chair of Research, Department of Neurosurgery
Brigham and Women’s Hospital
Associate Professor, Harvard Medical School
Principal Faculty Harvard Stem Cell Institute
Khalid is an Associate Professor at Harvard Medical School and the Director of the Center for Stem Cell Therapeutics and Imaging at BWH. He is also the Vice Chair of Research for the Department of Neurosurgery at BWH and a Principal Faculty at Harvard Stem Cell Institute in Boston. In recent years, Khalid and his team have pioneered major developments in the stem cell therapy field, successfully developing experimental models to understand basic cancer biology and therapeutic stem cells for cancer, particularly brain tumors. These studies have been published in a number of very high impact journals like Nature Neuroscience, PNAS, Nature Reviews Cancer, JNCI, Stem Cells and Lancet Oncology. Recently, Khalid’s work has caught the attention in the public domain and as such it has been highlighted in the media world-wide including features on BBC and CNN. Khalid holds current positions on numerous councils, advisory and editorial boards in the fields of stem cell therapy and oncology. In an effort to translate the exciting therapies developed in his laboratory into clinics, he has founded biotech company, AMASA Technologies Inc. whose main objective is the clinical translation of therapeutic stem cells in cancer patients.